Specialised Commissioning continues to be an issue of significance and uncertainty for both industry and the NHS. What do the latest reports of regional push back on the plans for devolution to ICBs mean?
What is the EU Joint Clinical Assessment (JCA) and what does it mean for market access and reimbursment in Euorpe?
We speak to Alka Singh about joining Mtech Access’ Systeamtic Review team. We learn about her career to date, her move to the UK and her experiences since joining the team.
How can the life sciences industry and the NHS work together to deliver real change? An overview of the key themes from our 2023 NHS Transformation Symposium.
Richard Marsh reflects on key themes from our NHS Transformation Symposium. He explores the operational and strategic challenges facing the NHS, the historic focus on inputs rather than outputs and the call put our by all our NHS speakers for a more collaborative relationship with and across industry.